Smoking (Tobacco) AddictionNCT07186049
Impact of Exercise Associated With Cognitive-behavioral Therapy in Smokers
A study testing Thesis Sessions, General Health Guidelines and Thesis and Exercises in people with Smoking (Tobacco) Addiction, run by Agnaldo José Lopes at 1 site in Brazil.
Trial summary
Smoking remains one of the leading causes of global morbidity and mortality, responsible for more than 8 million deaths annually, according to data from the World Health Organization. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Smoking (Tobacco) Addiction
- What is being tested?
- Thesis Sessions, General Health Guidelines and Thesis and Exercises
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 66 participants
- Where
- 1 siteBrazil
- Study dates
- 22 Oct 2025to 30 Jun 2028
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Participants 18 years of age or older;
- Clinical diagnosis of active smoking of combustible cigarettes;
Who cannot join
- Unstable heart disease or severe orthopedic problems;
- Cognitive disorders that may interfere with understanding and participation in behavioral interventions;
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Brazil1 site
PPC/UERJ - Piquet Carneiro University Polyclinic
Rio de Janeiro, Rio de Janeiro, 20950-003
Agnaldo J José, Docor, 5521998536162, alopes@souunisuam.com.br
About this study
Official title: Impact of Exercise Associated With Cognitive-behavioral Therapy in Smokers: a Randomized Clinical Trial
Smoking remains one of the leading causes of global morbidity and mortality, responsible for more than 8 million deaths annually, according to data from the World Health Organization. In addition to its physical effects, such as cancer, cardiovascular, and respiratory diseases, tobacco use also negatively impacts mental health and quality of life (QoL). Despite public health measures, its prevalence remains high, especially among vulnerable groups, requiring integrated approaches that address both the physiological and psychological aspects of addiction.
This study aims to evaluate the effects of combining physical exercise and cognitive behavioral therapy (CBT) on smoking cessation. Specifically, it seeks to assess the effectiveness of a structured exercise program in promoting abstinence, improving physical and mental health, and reducing cigarette consumption, as well as analyzing the impacts on fatigue, lung function, exercise capacity, and quality of life of participants over a 12-week intervention.
Read more
Methodologically, a randomized clinical trial will be conducted with 66 smokers recruited from the Piquet Carneiro Polyclinic of the Rio de Janeiro State University. Participants will be randomly assigned to three groups: CBT alone, CBT combined with structured exercises, and a control group with general health counseling. Assessments will include spirometry, impulse oscillometry, the FACIT-Fatigue scale, the Fagerström test, a cardiopulmonary exercise test, and the SF-36 questionnaire, administered at three time points: baseline, 6 weeks, and 12 weeks.
The combination of exercise and CBT is expected to significantly increase abstinence rates, promoting improvements in physical and mental health parameters, reduced cigarette consumption, increased exercise capacity, improved lung function, and decreased fatigue. Furthermore, a reduction in anxiety and depression levels is expected, reflecting the effectiveness of behavioral strategies in modulating the psychological factors associated with smoking.
This study is highly relevant to Rehabilitation Sciences, as it proposes an integrated intervention that can support the development of more effective and holistic public health programs aligned with national targets and the Sustainable Development Goals. By exploring the interface between physical activity, mental health, and smoking cessation, it contributes to the training of more qualified health professionals and the advancement of patient-centered rehabilitation strategies, promoting sustainable benefits to public health.
Read the detailed description
Detailed Description of the Thesis Title: Impact of Exercise Combined with Cognitive-Behavioral Therapy in Smokers: A Randomized Clinical Trial
Objectives
General Objective:
To evaluate the effects of combining physical exercise interventions with cognitive-behavioral therapy on smoking cessation among adult smokers.
Specific Objectives:
To assess the efficacy of a structured physical exercise program in promoting smoking cessation and improving the physical and mental health of participants.
To evaluate changes in smoking behaviors, including frequency and quantity of cigarettes smoked, during the clinical trial.
To analyze the effects of the combined intervention on general fatigue, lung function, and exercise capacity.
To measure the quality of life (QoL) of smokers before and after the intervention, considering physical, emotional, and social aspects.
Scientific Rationale and Relevance The scientific relevance of this study lies in its potential to inform the development of integrated rehabilitation strategies that address both cessation and the sequelae of tobacco use. The research aligns with national health priorities, particularly those related to chronic non-communicable diseases (NCDs), and supports the Sustainable Development Goals (SDGs) of the United Nations, notably SDG 3 (Good Health and Well-being). By focusing on the intersection of physical activity, mental health, and tobacco cessation, the study aims to contribute to the formation of better-trained health professionals and the development of patient-centered, holistic public health policies.
Methodology Study Design This is a randomized, controlled, parallel-group clinical trial with a 12-week intervention period. The study will be conducted at the Piquet Carneiro University Polyclinic (PPC), State University of Rio de Janeiro (UERJ), Brazil. The protocol will be preregistered on ClinicalTrials.gov to ensure methodological transparency and reproducibility.
Sample and Recruitment A total of 66 adult smokers will be recruited from the Anti-Smoking Program Outpatient Clinic at PPC-UERJ. The inclusion criteria are: age 18 years or older, clinical diagnosis of active smoking (combustible cigarettes), and availability to participate in all phases of the study. Exclusion criteria include unstable cardiac conditions, severe orthopedic problems, cognitive disorders that may interfere with participation, and concurrent involvement in other cessation or behavioral intervention studies.
Recruitment will be systematic, with the collaboration of the clinic's medical staff to ensure a diverse and representative sample. The sample size was calculated using G*Power 3.1, considering a one-way ANOVA with three independent groups, a significance level of 0.05, statistical power of 80%, and a large effect size (f = 0.40). To account for potential dropouts (estimated at 20%), the final sample size may be increased to approximately 81 participants.
Randomization and Groups
Participants will be randomly allocated into three parallel groups using block randomization with a specific software tool:
Group 1 (CBT): Participants receive only cognitive-behavioral therapy, focusing on behavioral modification strategies and motivational interviewing.
Group 2 (CBT + Exercise): Participants receive both CBT and a structured, supervised physical exercise program, including home-based sessions and weekly remote follow-up.
Group 3 (Control): Participants receive only general health education, with no supervised exercise or CBT.
Interventions CBT Protocol: Weekly sessions, based on motivational interviewing and the Stages of Change Model (Prochaska and DiClemente), addressing the psychological and behavioral aspects of tobacco dependence. The intervention is tailored to the individual's readiness to change, focusing on goal setting, overcoming barriers, and reinforcing positive behaviors.
Exercise Protocol: Home-based functional and aerobic exercise sessions, three times per week for 12 weeks, including warm-up, muscle strengthening, postural control, aerobic circuits, and stretching. Adherence is monitored via activity logs and weekly video submissions.
Control Group: Receives standard health advice only. Assessments Assessments are conducted at three time points: baseline (week 0), intermediate (week 6), and post-intervention (week 12). All instruments used are validated for the target population and administered by trained staff.
Clinical Evaluation: Sociodemographic data, medical history, smoking habits, and physical examination.
Fatigue Assessment: FACIT-Fatigue Scale (FACIT-F), a 13-item Likert scale measuring perceived fatigue.
Quality of Life: SF-36 questionnaire, covering physical, emotional, and social domains.
Pulmonary Function: Spirometry (measuring FVC, FEV1, FEV1/FVC, FEF25-75%) and impulse oscillometry (measuring respiratory resistance and reactance at various frequencies).
Nicotine Dependence: Fagerström Test for Nicotine Dependence (FTND), a 6-item scale.
Exercise Capacity: Cardiopulmonary exercise testing (CPET) using FitMate™ PRO, measuring peak oxygen consumption (VO2peak), ventilatory parameters, and functional reserve.
Adherence and Safety: Monitored throughout the study, with protocols for managing adverse events and withdrawal criteria.
Outcomes
Primary Outcome:
Smoking cessation rate, defined as the percentage of participants who remain abstinent during the follow-up period, confirmed by self-report and biochemical verification (cotinine levels and/or exhaled CO).
Secondary Outcomes:
Reduction in frequency and quantity of cigarettes smoked. Improvements in exercise capacity (VO2peak), pulmonary function, and general fatigue.
Enhanced quality of life (SF-36 scores). Changes in nicotine dependence (FTND scores). Adherence to intervention protocols. Data Analysis
Data will be managed in Microsoft Excel® and analyzed using IBM SPSS Statistics® (version 26.0). Statistical analyses include:
Descriptive statistics for all variables. Normality testing (Shapiro-Wilk). ANOVA for group comparisons (parametric data), Kruskal-Wallis for non-parametric data.
Chi-square or Fisher's exact test for categorical data. Post-hoc analyses (Tukey or Dunn with Bonferroni correction) for significant group differences.
Repeated measures ANOVA or Friedman test for within-group comparisons over time.
Logistic regression for analyzing the association between intervention type and smoking cessation, adjusting for covariates.
ANCOVA for secondary outcomes, controlling for baseline values. Significance set at p < 0.05, with 95% confidence intervals. Ethical Considerations The research protocol will be submitted to the Ethics Committee via Plataforma Brasil, in compliance with Resolution 466/2012 of the National Health Council and Law No. 14.874/2024 on human research. All participants will provide informed consent and will be assured of confidentiality, the right to withdraw, and access to clinical or psychological care if needed. The study includes provisions for reimbursement of travel expenses in cases of financial hardship and protocols for managing unexpected risks or adverse events.
Funding and Timeline The study is funded by the Brazilian Coordination for the Improvement of Higher Education Personnel (CAPES). The timeline includes project development, ethical approval, data collection, analysis, manuscript preparation, and dissemination of results over a period from 2025 to 2028.
Expected Results It is anticipated that the combined intervention group (CBT + Exercise) will demonstrate a significantly higher smoking abstinence rate compared to the control group, along with greater improvements in physical capacity, pulmonary function, fatigue reduction, and quality of life. The study also expects to observe positive changes in mental health parameters, such as reduced anxiety and depression, and increased adherence to healthy behaviors.
The findings will provide evidence to support the integration of physical and behavioral interventions in tobacco cessation programs, potentially influencing clinical practice guidelines and public health policy. The research aims to bridge gaps in current knowledge regarding the synergistic effects of exercise and CBT, contributing to more effective, patient-centered rehabilitation strategies.
Hypothesis:
This doctoral research presents a rigorous, innovative approach to smoking cessation, integrating physical exercise and cognitive-behavioral therapy within a randomized clinical trial framework. By addressing both the physiological and psychological dimensions of tobacco dependence, the study seeks to generate robust evidence to inform the design of holistic, sustainable health interventions. The expected outcomes have the potential to reduce the burden of smoking-related diseases, improve individual and population health, and support the development of more effective public health policies.
- Conditions
- Smoking (Tobacco) Addiction
- Being tested
- Thesis Sessions, General Health Guidelines, Thesis and Exercises
- Keywords
- Smoking; Physical exercise; Cognitive-behavioral therapy
- Medical subject headings
- Smoking, Behavior, Addictive, Motor Activity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Thesis SessionsBehavioural
Thesis Sessions
General Health GuidelinesBehavioural
General Health Guidelines
Thesis and ExercisesBehavioural
Thesis and Exercises
| Study group | Role | What they receive |
|---|---|---|
| Group 3 General Health Guidelines. | Active comparator | General Health Guidelines Receives: Behavioral: General Health Guidelines |
| Group 1 Thesis | Active comparator | Thesis Sessions Receives: Behavioral: Thesis Sessions |
| Group 2 Thesis and Exercises | Active comparator | Thesis Sessions + Home Exercises Receives: Behavioral: Thesis and Exercises |
What is being measured
The primary outcome is the main question the study is designed to answer.
The smoking cessation rate
The primary outcome of this study is the smoking cessation rate, defined as the percentage of participants who remain abstinent from tobacco use during the follow-up period. To ensure the robustness of the results, abstinence will be verified by participants' self-reports and confirmed by biochemical measures performed by physicians, such as blood cotinine levels and/or exhaled carbon monoxide (CO) testing. The selection of this primary outcome is based on the clinical relevance of achieving smoking cessation, as it contributes to improved individual health and serves as a direct indicator of the effectiveness of the proposed combined intervention.
Measured: 12 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Sep 2025
- Study start22 Oct 2025 (estimated)
- Primary completion30 Apr 2027 (estimated)
- Study completion30 Jun 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Smoking (Tobacco) AddictionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Randomized Intervention Study
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 66 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Agnaldo José Lopes
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Agnaldo José Lopes, Centro Universitário Augusto Motta
- Investigators
- Agnaldo J José, Principal investigator, Augusto Motta University Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07186049
- Sponsor's protocol ID
- 02565743750
- Status last verified
- Sep 2025
- First submitted
- 12 Sep 2025
- Last updated
- 30 Sep 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided: I'm still not sure; I will talk to my advisor
Study at a glance
From the registry record, last updated by the sponsor on 30 Sep 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Impact of Exercise Associated With Cognitive-behavioral Therapy in Smokers: a Randomized Clinical Trial
- ClinicalTrials.gov ID
- NCT07186049
- Acronym / sponsor ID
- 02565743750
- Conditions
- Smoking (Tobacco) Addiction
- Keywords
- Smoking; Physical exercise; Cognitive-behavioral therapy
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 66 participants (estimated)
- Lead sponsor
- Agnaldo José LopesUniversity, hospital or other
- Study start
- 22 Oct 2025 (estimated)
- Primary completion
- 30 Apr 2027 (estimated)
- Study completion
- 30 Jun 2028 (estimated)
- First posted
- 22 Sep 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Smoking remains one of the leading causes of global morbidity and mortality, responsible for more than 8 million deaths annually, according to data from the World Health Organization. In addition to its physical effects, such as cancer, cardiovascular, and respiratory diseases, tobacco use also negatively impacts mental health and quality of life (QoL). Despite public health measures, its prevalence remains high, especially among vulnerable groups, requiring integrated approaches that address both the physiological and psychological aspects of addiction.
This study aims to evaluate the effects of combining physical exercise and cognitive behavioral therapy (CBT) on smoking cessation. Specifically, it seeks to assess the effectiveness of a structured exercise program in promoting abstinence, improving physical and mental health, and reducing cigarette consumption, as well as analyzing the impacts on fatigue, lung function, exercise capacity, and quality of life of participants over a 12-week intervention.
Methodologically, a randomized clinical trial will be conducted with 66 smokers recruited from the Piquet Carneiro Polyclinic of the Rio de Janeiro State University. Participants will be randomly assigned to three groups: CBT alone, CBT combined with structured exercises, and a control group with general health counseling. Assessments will include spirometry, impulse oscillometry, the FACIT-Fatigue scale, the Fagerström test, a cardiopulmonary exercise test, and the SF-36 questionnaire, administered at three time points: baseline, 6 weeks, and 12 weeks.
The combination of exercise and CBT is expected to significantly increase abstinence rates, promoting improvements in physical and mental health parameters, reduced cigarette consumption, increased exercise capacity, improved lung function, and decreased fatigue. Furthermore, a reduction in anxiety and depression levels is expected, reflecting the effectiveness of behavioral strategies in modulating the psychological factors associated with smoking.
This study is highly relevant to Rehabilitation Sciences, as it proposes an integrated intervention that can support the development of more effective and holistic public health programs aligned with national targets and the Sustainable Development Goals. By exploring the interface between physical activity, mental health, and smoking cessation, it contributes to the training of more qualified health professionals and the advancement of patient-centered rehabilitation strategies, promoting sustainable benefits to public health.
Detailed description
Detailed Description of the Thesis Title: Impact of Exercise Combined with Cognitive-Behavioral Therapy in Smokers: A Randomized Clinical Trial
Objectives
General Objective:
To evaluate the effects of combining physical exercise interventions with cognitive-behavioral therapy on smoking cessation among adult smokers.
Specific Objectives:
To assess the efficacy of a structured physical exercise program in promoting smoking cessation and improving the physical and mental health of participants.
To evaluate changes in smoking behaviors, including frequency and quantity of cigarettes smoked, during the clinical trial.
To analyze the effects of the combined intervention on general fatigue, lung function, and exercise capacity.
To measure the quality of life (QoL) of smokers before and after the intervention, considering physical, emotional, and social aspects.
Scientific Rationale and Relevance The scientific relevance of this study lies in its potential to inform the development of integrated rehabilitation strategies that address both cessation and the sequelae of tobacco use. The research aligns with national health priorities, particularly those related to chronic non-communicable diseases (NCDs), and supports the Sustainable Development Goals (SDGs) of the United Nations, notably SDG 3 (Good Health and Well-being). By focusing on the intersection of physical activity, mental health, and tobacco cessation, the study aims to contribute to the formation of better-trained health professionals and the development of patient-centered, holistic public health policies.
Methodology Study Design This is a randomized, controlled, parallel-group clinical trial with a 12-week intervention period. The study will be conducted at the Piquet Carneiro University Polyclinic (PPC), State University of Rio de Janeiro (UERJ), Brazil. The protocol will be preregistered on ClinicalTrials.gov to ensure methodological transparency and reproducibility.
Sample and Recruitment A total of 66 adult smokers will be recruited from the Anti-Smoking Program Outpatient Clinic at PPC-UERJ. The inclusion criteria are: age 18 years or older, clinical diagnosis of active smoking (combustible cigarettes), and availability to participate in all phases of the study. Exclusion criteria include unstable cardiac conditions, severe orthopedic problems, cognitive disorders that may interfere with participation, and concurrent involvement in other cessation or behavioral intervention studies.
Recruitment will be systematic, with the collaboration of the clinic's medical staff to ensure a diverse and representative sample. The sample size was calculated using G*Power 3.1, considering a one-way ANOVA with three independent groups, a significance level of 0.05, statistical power of 80%, and a large effect size (f = 0.40). To account for potential dropouts (estimated at 20%), the final sample size may be increased to approximately 81 participants.
Randomization and Groups
Participants will be randomly allocated into three parallel groups using block randomization with a specific software tool:
Group 1 (CBT): Participants receive only cognitive-behavioral therapy, focusing on behavioral modification strategies and motivational interviewing.
Group 2 (CBT + Exercise): Participants receive both CBT and a structured, supervised physical exercise program, including home-based sessions and weekly remote follow-up.
Group 3 (Control): Participants receive only general health education, with no supervised exercise or CBT.
Interventions CBT Protocol: Weekly sessions, based on motivational interviewing and the Stages of Change Model (Prochaska and DiClemente), addressing the psychological and behavioral aspects of tobacco dependence. The intervention is tailored to the individual's readiness to change, focusing on goal setting, overcoming barriers, and reinforcing positive behaviors.
Exercise Protocol: Home-based functional and aerobic exercise sessions, three times per week for 12 weeks, including warm-up, muscle strengthening, postural control, aerobic circuits, and stretching. Adherence is monitored via activity logs and weekly video submissions.
Control Group: Receives standard health advice only. Assessments Assessments are conducted at three time points: baseline (week 0), intermediate (week 6), and post-intervention (week 12). All instruments used are validated for the target population and administered by trained staff.
Clinical Evaluation: Sociodemographic data, medical history, smoking habits, and physical examination.
Fatigue Assessment: FACIT-Fatigue Scale (FACIT-F), a 13-item Likert scale measuring perceived fatigue.
Quality of Life: SF-36 questionnaire, covering physical, emotional, and social domains.
Pulmonary Function: Spirometry (measuring FVC, FEV1, FEV1/FVC, FEF25-75%) and impulse oscillometry (measuring respiratory resistance and reactance at various frequencies).
Nicotine Dependence: Fagerström Test for Nicotine Dependence (FTND), a 6-item scale.
Exercise Capacity: Cardiopulmonary exercise testing (CPET) using FitMate™ PRO, measuring peak oxygen consumption (VO2peak), ventilatory parameters, and functional reserve.
Adherence and Safety: Monitored throughout the study, with protocols for managing adverse events and withdrawal criteria.
Outcomes
Primary Outcome:
Smoking cessation rate, defined as the percentage of participants who remain abstinent during the follow-up period, confirmed by self-report and biochemical verification (cotinine levels and/or exhaled CO).
Secondary Outcomes:
Reduction in frequency and quantity of cigarettes smoked. Improvements in exercise capacity (VO2peak), pulmonary function, and general fatigue.
Enhanced quality of life (SF-36 scores). Changes in nicotine dependence (FTND scores). Adherence to intervention protocols. Data Analysis
Data will be managed in Microsoft Excel® and analyzed using IBM SPSS Statistics® (version 26.0). Statistical analyses include:
Descriptive statistics for all variables. Normality testing (Shapiro-Wilk). ANOVA for group comparisons (parametric data), Kruskal-Wallis for non-parametric data.
Chi-square or Fisher's exact test for categorical data. Post-hoc analyses (Tukey or Dunn with Bonferroni correction) for significant group differences.
Repeated measures ANOVA or Friedman test for within-group comparisons over time.
Logistic regression for analyzing the association between intervention type and smoking cessation, adjusting for covariates.
ANCOVA for secondary outcomes, controlling for baseline values. Significance set at p < 0.05, with 95% confidence intervals. Ethical Considerations The research protocol will be submitted to the Ethics Committee via Plataforma Brasil, in compliance with Resolution 466/2012 of the National Health Council and Law No. 14.874/2024 on human research. All participants will provide informed consent and will be assured of confidentiality, the right to withdraw, and access to clinical or psychological care if needed. The study includes provisions for reimbursement of travel expenses in cases of financial hardship and protocols for managing unexpected risks or adverse events.
Funding and Timeline The study is funded by the Brazilian Coordination for the Improvement of Higher Education Personnel (CAPES). The timeline includes project development, ethical approval, data collection, analysis, manuscript preparation, and dissemination of results over a period from 2025 to 2028.
Expected Results It is anticipated that the combined intervention group (CBT + Exercise) will demonstrate a significantly higher smoking abstinence rate compared to the control group, along with greater improvements in physical capacity, pulmonary function, fatigue reduction, and quality of life. The study also expects to observe positive changes in mental health parameters, such as reduced anxiety and depression, and increased adherence to healthy behaviors.
The findings will provide evidence to support the integration of physical and behavioral interventions in tobacco cessation programs, potentially influencing clinical practice guidelines and public health policy. The research aims to bridge gaps in current knowledge regarding the synergistic effects of exercise and CBT, contributing to more effective, patient-centered rehabilitation strategies.
Hypothesis:
This doctoral research presents a rigorous, innovative approach to smoking cessation, integrating physical exercise and cognitive-behavioral therapy within a randomized clinical trial framework. By addressing both the physiological and psychological dimensions of tobacco dependence, the study seeks to generate robust evidence to inform the design of holistic, sustainable health interventions. The expected outcomes have the potential to reduce the burden of smoking-related diseases, improve individual and population health, and support the development of more effective public health policies.
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 3
- Model description
- Randomized Intervention Study
| Arm | Type | Receives |
|---|---|---|
| Group 3 General Health Guidelines. | Active comparator | Behavioral: General Health GuidelinesGeneral Health Guidelines |
| Group 1 Thesis | Active comparator | Behavioral: Thesis SessionsThesis Sessions |
| Group 2 Thesis and Exercises | Active comparator | Behavioral: Thesis and ExercisesThesis Sessions + Home Exercises |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- Participants 18 years of age or older;
- Clinical diagnosis of active smoking of combustible cigarettes;
Key exclusion criteria (2 listed)
- Unstable heart disease or severe orthopedic problems;
- Cognitive disorders that may interfere with understanding and participation in behavioral interventions;
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Thesis SessionsThesis Sessions | Behavioural | Group 1 Thesis |
| General Health GuidelinesGeneral Health Guidelines | Behavioural | Group 3 General Health Guidelines. |
| Thesis and ExercisesThesis and Exercises | Behavioural | Group 2 Thesis and Exercises |
Primary outcome
The smoking cessation rate
Time frame: 12 weeks
The primary outcome of this study is the smoking cessation rate, defined as the percentage of participants who remain abstinent from tobacco use during the follow-up period. To ensure the robustness of the results, abstinence will be verified by participants' self-reports and confirmed by biochemical measures performed by physicians, such as blood cotinine levels and/or exhaled carbon monoxide (CO) testing. The selection of this primary outcome is based on the clinical relevance of achieving smoking cessation, as it contributes to improved individual health and serves as a direct indicator of the effectiveness of the proposed combined intervention.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 Sep 2025.
- Individual participant dataSharing planned: Undecided. I'm still not sure; I will talk to my advisor
Related trials for Smoking (Tobacco) Addiction
RecruitingPhase 4
Addiction Potential of Very Low Nicotine Filtered Little Cigars
Smoking (Tobacco) Addiction
Not yet recruiting
QAIAx - SGI/SI Smart Health Cities: Microcity Enclave Program (Quantum SI/AGI Agency a/k/a AI City Hall Project - UPSTO App Nos. 64/074,526, 64/063,557, 64/105,164, 63/903,181, 63/729,428, 64/125,360; USPTO EO 9424 Assignment ID: 2101042 / ARN: REEL/FRAME: 76481/0026 - OUSD-R&E, Department of War)
Asperger's Disorder, Asperger Disorder
Active, not recruiting
THE EFFECT OF A TRANSTHEORETICAL MODEL-BASED CHATBOT SUPPORT INTERVENTION ON SMOKING BEHAVIOR IN UNIVERSITY STUDENTS
Smoking ( Cigarette), Smoking (Tobacco) Addiction
Recruiting
Interventional Study on Smoking Reduction in Psychiatry
Tobacco Addiction
Recruiting
Circuitry-Guided Smoking Cessation in Schizophrenia (UH3)
Smoking Cessation, Nicotine Addiction
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Agnaldo J José principal investigator
Augusto Motta University Center
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Thesis Sessions, General Health Guidelines and Thesis and Exercises in people with Smoking (Tobacco) Addiction, run by Agnaldo José Lopes at 1 site in Brazil.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 30 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact JORGE M PINTO, doctoral student (21964443667, JORGETITIRY@GMAIL.COM), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
The smoking cessation rate (time frame: 12 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Sep 2025.